Schabort E J, Wilson G, Noakes T D
Sports Science Institute of South Africa, Newlands.
Eur J Appl Physiol. 2000 Nov;83(4 -5):320-7. doi: 10.1007/s004210000264.
The purpose of the current investigation was to determine whether sodium citrate enhances endurance cycling performance and, if so, what dosage(s) produces this effect. Eight trained [peak power output: 362 (48) W; power:weight: 5.1 (0.4) W x kg(-1), mean (SD)] male cyclists were requested to complete four, 40-km time-trials, each separated by 3-7 days, on their own bicycles, mounted on a Kingcycle ergometer. To mimic the stochastic nature of cycle road races, the time-trials included four 500-m, four 1-km and two 2-km sprints. The experimental conditions involved the ingestion of three dosages of sodium citrate dissolved in 400 ml water: 0.2 g x kg(-1), 0.4 g x kg(-1) and 0.6 g x kg(-1) body mass (b.m.) and a placebo (calcium carbonate, 0.1 g x kg(-1) b.m.). Subjects were asked to complete both the sprints and total distance in the fastest time possible. Venous blood samples were collected before, as well as at 10-km intervals during the trials for the analysis of plasma lactate and glucose concentrations and for the measurement of blood pH and PCO2 levels. Immediately before, as well as during exercise, pH was significantly higher in the group ingesting the highest citrate dose (range 7.36-7.45) compared to the placebo (range 7.31-7.39) and the two lower citrate dosages. Despite this, no significant differences in power output (P = 0.886) or time taken to complete the 40 km (P = 0.754) were measured between the four trials. The average performance times (in min:s, with SD in parentheses) and average power output (in W) for the 40-km time-trials were: 58:46 (5:06) [265 (62) W], 60:24 (6:07) [251 (59) W], 61:47 (5:07) [243 (44) W] and 60:02 (5.05) [255 (55) W] for the 0.2, 0.4, 0.6 g x kg(-1) b.m. sodium citrate and placebo trials, respectively. There were also no significant differences measured between treatments in terms of time, power output, speed or heart rate during the 500-m, 1-km and 2-km sprints. The ingestion of increasing sodium citrate dosages before exercise produced dose-dependent changes in pH, base excess and HCO3- concentrations before and during the 40-km time-trial. However, these changes influenced neither the time-trial time nor the sprinting performance times.
本次研究的目的是确定柠檬酸钠是否能提高耐力自行车运动表现,如果能,何种剂量可产生此效果。八名训练有素的男性自行车运动员[峰值功率输出:362(48)瓦;功率:体重:5.1(0.4)瓦/千克,均值(标准差)]被要求在安装于Kingcycle测力计上的自己的自行车上完成四次40公里的计时赛,每次计时赛间隔3 - 7天。为模拟自行车公路赛的随机性,计时赛包括四次500米、四次1公里和两次2公里的冲刺。实验条件包括摄入三种溶解于400毫升水中的柠檬酸钠剂量:0.2克/千克、0.4克/千克和0.6克/千克体重(b.m.)以及一种安慰剂(碳酸钙,0.1克/千克体重)。要求受试者尽可能快地完成冲刺和总距离。在试验前以及试验期间每隔10公里采集静脉血样,用于分析血浆乳酸和葡萄糖浓度以及测量血液pH值和PCO2水平。在运动前及运动期间,摄入最高柠檬酸钠剂量组(范围7.36 - 7.45)的pH值显著高于安慰剂组(范围7.31 - 7.39)和两个较低柠檬酸钠剂量组。尽管如此,四次试验之间在功率输出(P = 0.886)或完成40公里所需时间(P = 0.754)方面未测得显著差异。40公里计时赛的平均成绩时间(分钟:秒,括号内为标准差)和平均功率输出(瓦)分别为:0.2克/千克体重柠檬酸钠试验组58:46(5:06)[265(62)瓦]、0.4克/千克体重柠檬酸钠试验组60:24(6:07)[251(59)瓦]、0.6克/千克体重柠檬酸钠试验组61:47(5:07)[243(44)瓦]和安慰剂试验组60:02(5.05)[255(55)瓦]。在500米、1公里和2公里冲刺期间,各处理组在时间、功率输出、速度或心率方面也未测得显著差异。运动前摄入递增剂量的柠檬酸钠会使40公里计时赛前后及期间的pH值、碱剩余和HCO3-浓度产生剂量依赖性变化。然而,这些变化既未影响计时赛时间,也未影响冲刺成绩时间。